Amatuximab, CAS 931402-35-6

Product Description: Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Hassan R, et al. Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma. Clin Cancer Res. 2014;20(23):5927-5936. /[2]Baldo P, et al. Amatuximab and novel agents targeting mesothelin for solid tumors. Onco Targets Ther. 2017;10:5337-5353. Published 2017 Nov 8.

CAS Number: 931402-35-6

Molecular Weight: N/A

Compound Purity: 99.90

Research Area: Cancer

Solubility: H2O

Target: Mesothelin

• Artikelnummer: MEXHY-P99006-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99006-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK